Philips Accelerates Stroke Diagnosis And Treatment, Inks Strategic Partnership With MedTech NICO.LAB

Royal Philips PHG announced a strategic partnership agreement with NICO.LAB, a MedTech stroke care company, significantly advancing Philips’ commitment to improving outcomes for people who suffer a stroke.
This partnership brings a cloud-based, end-to-end artificial intelligence (AI) based stroke triage and management solution, ‘StrokeViewer,’ to improve patient outcomes by optimizing the stroke workflow.
It analyzes CT scan data with AI and automatically detects large vessel occlusion and its location.
The company believes that with its integrated portfolio and validated AI and cloud technologies, it can facilitate collaborative care to optimize the stroke care pathway from diagnosis to treatment.
Philips’ stroke portfolio includes solutions for stroke monitoring and communication in ambulances, tele-stroke patient assessment, diagnostic imaging and analysis, image-guided therapy, neurological monitoring and assessment, and more.
Price Action: PHG shares are down 0.17% at $47.61 on the last check Wednesday.

Momentum28.21

Growth43.28

Quality15.53

Value18.43

Short

Medium

Long